{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:53:45Z","timestamp":1791201225459,"version":"4.2.0"},"reference-count":87,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,3,22]],"date-time":"2015-03-22T00:00:00Z","timestamp":1426982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swedish government"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Intern Med"],"published-print":{"date-parts":[[2015,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Type 1 narcolepsy is a neurological disorder characterized by excessive daytime sleepiness and cataplexy associated with the <jats:italic><jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content><\/jats:italic> allele <jats:italic><jats:styled-content style=\"fixed-case\">DQB<\/jats:styled-content>1*06:02<\/jats:italic>. Genetic predisposition along with external triggering factors may drive autoimmune responses, ultimately leading to the selective loss of hypocretin\u2010positive neurons.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of this study was to investigate potential aetiological factors in Swedish cases of postvaccination (Pandemrix) narcolepsy defined by interferon\u2010gamma (<jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u03b3) production from immune cells in response to molecularly defined targets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Cellular reactivity defined by <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u03b3 production was examined in blood from 38 (<jats:italic><jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">DQB<\/jats:styled-content>1*06:02<\/jats:italic><jats:sup>+<\/jats:sup>) Pandemrix\u2010vaccinated narcolepsy cases and 76 (23 <jats:italic><jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">DQB<\/jats:styled-content>1*06:02<\/jats:italic><jats:sup>+<\/jats:sup> and 53 <jats:italic><jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">DQB<\/jats:styled-content>1*06:02<\/jats:italic><jats:sup>\u2212<\/jats:sup>) control subjects, matched for age, sex and exposure, using a variety of different antigens: \u03b2\u2010haemolytic group A streptococcal (<jats:styled-content style=\"fixed-case\">GAS<\/jats:styled-content>) antigens (M5, M6 and streptodornase B), influenza (the pandemic A\/H1N1\/California\/7\/09 <jats:styled-content style=\"fixed-case\">NYMC<\/jats:styled-content> X\u2010179A and A\/H1N1\/California\/7\/09 <jats:styled-content style=\"fixed-case\">NYMC<\/jats:styled-content> X\u2010181 vaccine antigens, previous Flu\u2010A and \u2010B vaccine targets, A\/H1N1\/Brisbane\/59\/2007, A\/H1N1\/Solomon Islands\/3\/2006, A\/H3N2\/Uruguay\/716\/2007, A\/H3N2\/Wisconsin\/67\/2005, A\/H5N1\/Vietnam\/1203\/2004 and B\/Malaysia\/2506\/2004), noninfluenza viral targets (<jats:styled-content style=\"fixed-case\">CMV<\/jats:styled-content>pp65, <jats:styled-content style=\"fixed-case\">EBNA<\/jats:styled-content>\u20101 and <jats:styled-content style=\"fixed-case\">EBNA<\/jats:styled-content>\u20103) and auto\u2010antigens (hypocretin peptide, Tribbles homolog 2 peptide cocktail and extract from rat hypothalamus tissue).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b3 production was significantly increased in whole blood from narcolepsy cases in response to streptococcus serotype M6 (<jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0.0065) and streptodornase B protein (<jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0.0050). T\u2010cell recognition of M6 and streptodornase B was confirmed at the single\u2010cell level by intracellular cytokine (<jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20102, <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u03b3, tumour necrosis factor\u2010alpha and <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017) production after stimulation with synthetic M6 or streptodornase B peptides. Significantly, higher (<jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0.02) titres of serum antistreptolysin O were observed in narcolepsy cases, compared to vaccinated controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>\u03b2\u2010haemolytic <jats:styled-content style=\"fixed-case\">GAS<\/jats:styled-content> may be involved in triggering autoimmune responses in patients who developed narcolepsy symptoms after vaccination with Pandemrix in Sweden, characterized by a <jats:italic>Streptococcus pyogenes<\/jats:italic> M\u2010type\u2010specific <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b3 cellular immune response.<\/jats:p><\/jats:sec>","DOI":"10.1111\/joim.12355","type":"journal-article","created":{"date-parts":[[2015,2,14]],"date-time":"2015-02-14T07:23:09Z","timestamp":1423898589000},"page":"264-276","source":"Crossref","is-referenced-by-count":33,"title":["Increased \u03b2\u2010haemolytic group A streptococcal M6 serotype and streptodornase B\u2010specific cellular immune responses in Swedish narcolepsy cases"],"prefix":"10.1111","volume":"278","author":[{"given":"A.","family":"Ambati","sequence":"first","affiliation":[{"name":"Department of Medicine Karolinska Institutet Stockholm Sweden"},{"name":"Centre for Allogeneic Stem Cell Transplantation Karolinska University Hospital Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Poiret","sequence":"additional","affiliation":[{"name":"Division of Therapeutic Immunology Department of Laboratory Medicine Karolinska Institutet Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.\u2010M.","family":"Svahn","sequence":"additional","affiliation":[{"name":"Centre for Allogeneic Stem Cell Transplantation Karolinska University Hospital Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Valentini","sequence":"additional","affiliation":[{"name":"Centre for Allogeneic Stem Cell Transplantation Karolinska University Hospital Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Khademi","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience Karolinska Institutet Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Kockum","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience Karolinska Institutet Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Lima","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience Karolinska Institutet Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Arnheim\u2010Dahlstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lamb","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Fink","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience Karolinska Institutet Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Meng","sequence":"additional","affiliation":[{"name":"Division of Therapeutic Immunology Department of Laboratory Medicine Karolinska Institutet Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences University of Cagliari Cagliari Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Rane","sequence":"additional","affiliation":[{"name":"Division of Therapeutic Immunology Department of Laboratory Medicine Karolinska Institutet Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Olsson","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience Karolinska Institutet Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maeurer","sequence":"additional","affiliation":[{"name":"Centre for Allogeneic Stem Cell Transplantation Karolinska University Hospital Stockholm Sweden"},{"name":"Division of Therapeutic Immunology Department of Laboratory Medicine Karolinska Institutet Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,3,22]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-193413010-00001"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1086\/318799"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70075-4"},{"key":"e_1_2_8_5_1","first-page":"1012","article-title":"HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients","volume":"20","author":"Mignot E","year":"1997","journal-title":"Sleep"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/17.suppl_8.S60"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05582-8"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)00058-1"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/79690"},{"key":"e_1_2_8_10_1","unstructured":"Swedish Medical Product Agency (MPA).Registry study confirms increased risk of narcolepsy after vaccination with Pandemrix in children and adolescents and shows an increased risk in young adults.2013. Available from:http:\/\/www.lakemedelsverket.se\/english\/All-news\/NYHETER-2013\/Registrystudy-confirms-increased-risk-of-narcolepsy-after-vaccination-with-Pandemrix-inchildren-and-adolescents-and-shows-an-increased-risk-in-young-adults\/."},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033723"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/33.11.1428"},{"key":"e_1_2_8_13_1","unstructured":"THL F.N.I.f.H.a.W.National Institute for Health and Welfare recommends discontinuation of Pandemrix vaccinations 2010."},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033536"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.12.015"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31828ab26f"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2013.03.020"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70238-X"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12150"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41366"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/33.7.869"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013320"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.372"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2012.01948.x"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.734"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.4.1149"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2003.11.002"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.16.1739"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-313X.1995.tb00282.x"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2869.2009.00756.x"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/32.8.979"},{"key":"e_1_2_8_32_1","first-page":"201","article-title":"Elevated antibodies to streptococcal antigens in narcoleptic subjects","volume":"18","author":"Billiard M","year":"1989","journal-title":"Sleep Res"},{"key":"e_1_2_8_33_1","first-page":"271","article-title":"Streptococcal antibodies in narcolepsy and idiopathic hypersomnia","volume":"18","author":"Montplaisir J","year":"1989","journal-title":"Sleep Res"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90270-F"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22587"},{"key":"e_1_2_8_36_1","first-page":"620","article-title":"Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy","volume":"20","author":"Aldrich MS","year":"1997","journal-title":"Sleep"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-125"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2006.01.005"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2010.03284.x"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e3181c0c3cb"},{"key":"e_1_2_8_41_1","volume-title":"Laboratory diagnosis of group A streptococcal infections","author":"Johnson DR","year":"1997"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.3.807.003k24_807_814"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60327-118-9_13"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm266"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1039\/C4MB00203B"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr431"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/08916930500484674"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.47.1.91"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.167.3.1114"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.2.3.285"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/292457a0"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.110.2.271"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.89.3.307"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.4.1320"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr244"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199503000-00015"},{"key":"e_1_2_8_57_1","first-page":"706","article-title":"Sydenham's chorea: physical and psychological symptoms of St Vitus dance","volume":"91","author":"Swedo SE","year":"1993","journal-title":"Pediatrics"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.144.4.1094"},{"key":"e_1_2_8_59_1","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1001\/jama.1994.03520220082035","article-title":"Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders","volume":"272","author":"Swedo SE","year":"1994","journal-title":"JAMA"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1998.tb02952.x"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.162.2.583"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.3.470"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.166.6.1825"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.00600.x"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.9.5345-5351.2001"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-003-0062-2"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/165.5.879"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(05)70082-9"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2524876"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.1.285"},{"key":"e_1_2_8_71_1","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.4049\/jimmunol.151.3.1419","article-title":"Localization of an immunologically functional region of the streptococcal superantigen pepsin\u2010extracted fragment of type 5 M protein","volume":"151","author":"Wang B","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_8_72_1","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/iai.61.3.1062-1068.1993","article-title":"Characterization of a conserved helper\u2010T\u2010cell epitope from group A Streptococcal M proteins","volume":"61","author":"Robinson JH","year":"1993","journal-title":"Infect Immun"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.60.5.1767-1770.1992"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjr043"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050569"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.12.8761"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.6.3893"},{"key":"e_1_2_8_78_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1412189111"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2008.09.007"},{"key":"e_1_2_8_80_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/535738"},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70196-5"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/358155a0"},{"key":"e_1_2_8_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80470-7"},{"key":"e_1_2_8_84_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200001000-00009"},{"key":"e_1_2_8_85_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512448109"},{"key":"e_1_2_8_86_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2414848"},{"key":"e_1_2_8_87_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.279.5355.1344"},{"key":"e_1_2_8_88_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200113032"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjoim.12355","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjoim.12355","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/joim.12355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T20:31:36Z","timestamp":1696278696000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/joim.12355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,22]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.1111\/joim.12355"],"URL":"https:\/\/doi.org\/10.1111\/joim.12355","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,22]]}}}